6
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Hormonal Effects of Different Doses of Estramustine Phosphate (Estracyt®) in Patients with Prostatic Carcinoma

Gösta Jönsson in Memoriam

, , , , &
Pages 37-44 | Received 01 Mar 1979, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rolf Lundgren, Torsten Sundin, Stig Colleen, Eric Lindstedt, Lars Wadström, Stig Carlsson, Sverker Hellsten, Rolf Pompeius, Bo Holmquist, Torgny Nilsson, Sven Rubin, Wilhelm Luttropp & Hjalmar Jansen. (1986) Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma: A Preliminary Report from a Randomized Multicenter Study. Scandinavian Journal of Urology and Nephrology 20:2, pages 101-105.
Read now
P. O. Gunnarsson, G. Plym Forshell, Å. Fritjofsson & B. J. Norlén. (1981) Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).. Scandinavian Journal of Urology and Nephrology 15:3, pages 201-206.
Read now

Articles from other publishers (10)

Daisaku Hirano, Sadatsugu Minei, Yuichi Kishimoto, Kenya Yamaguchi, Takahiko Hachiya, Toshio Yoshida, Tetsuo Yoshikawa, Makoto Endoh, Yataroh Yamanaka, Tadao Yamamoto, Yasuo Satoh, Hajime Ishida, Kiyoki Okada & Yukie Takimoto. (2005) Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy. Urologia Internationalis 75:1, pages 43-49.
Crossref
Tadaichi Kitamura. (2008) Necessity of re‐evaluation of estramustine phosphate sodium (EMP) as a treatment option for first‐line monotherapy in advanced prostate cancer. International Journal of Urology 8:2, pages 33-36.
Crossref
Harkishan Singh, Dharam Paul Jindal, Mange Ram Yadav & Manoj Kumar. 1991. 233 300 .
MARGARETA WALLIN. 1988. Neuronal and Glial Proteins. Neuronal and Glial Proteins 321 338 .
Alvaro Morales & J. Curtis Nickel. (1985) Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate. Urology 26:5, pages 477-481.
Crossref
W. Vahlensieck, G. Wegner, H. D. Lehmann, G. Franzen, L. Steffens & S. W�hlby. (1985) Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate. Urological Research 13:5, pages 209-212.
Crossref
Stephan Rössner, P.-O. Hedlund, Tomas Jogestrand & Urbain Säwe. (1985) Treatment of Prostatic Cancer: Effects on Serum Lipoproteins and the Cardiovascular System. Journal of Urology 133:1, pages 53-57.
Crossref
F. M. Torti. 1983. Urologic Cancer: Chemotherapeutic Principles and Management. Urologic Cancer: Chemotherapeutic Principles and Management 58 69 .
F. Bussani, A. Patriti & A. Properzi. (2018) Il Trattamento Del Carcinoma Prostatico Con Estramustina Fosfato: Esperienza Clinica. Urologia Journal 49:6, pages 982-985.
Crossref
W. Hoehn, R. Walther & P. Hermanek. (2006) Human prostatic adenocarcinoma: Comparative experimental treatment of the tumor line pc 82 in nude mice. The Prostate 3:2, pages 193-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.